These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 1758875)
1. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers. Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875 [TBL] [Abstract][Full Text] [Related]
2. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Ponz de Leon M; Roncucci L; Di Donato P; Tassi L; Smerieri O; Amorico MG; Malagoli G; De Maria D; Antonioli A; Chahin NJ Cancer Res; 1988 Jul; 48(14):4121-6. PubMed ID: 3383201 [TBL] [Abstract][Full Text] [Related]
3. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls. Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331 [TBL] [Abstract][Full Text] [Related]
4. Growth kinetics of human colorectal carcinoma. Ota DM; Drewinko B Cancer Res; 1985 May; 45(5):2128-31. PubMed ID: 3986766 [TBL] [Abstract][Full Text] [Related]
5. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Paganelli GM; Lalli E; Facchini A; Biasco G; Santucci R; Brandi G; Barbara L Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307 [TBL] [Abstract][Full Text] [Related]
6. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Larsson P Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of cell kinetics in endometrial adenocarcinoma. Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664 [TBL] [Abstract][Full Text] [Related]
8. Thymidine labeling index in colorectal carcinoma: relation to clinicopathological parameters and to mitotic index. Matturri L; Biondo B; Lavezzi AM Cancer Detect Prev; 1997; 21(5):471-5. PubMed ID: 9307850 [TBL] [Abstract][Full Text] [Related]
9. Nucleotide fractional incorporation: a simple metabolic feature potentially related to clinical outcome in colorectal cancer patients. Franchi F; Seminara P; Izzo L; De Luca A; Truglia S; Aronne T; Caliò E; Costa A J Exp Clin Cancer Res; 1998 Dec; 17(4):401-4. PubMed ID: 10089057 [TBL] [Abstract][Full Text] [Related]
10. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk. Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in proliferation markers in colorectal cancer. Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859 [TBL] [Abstract][Full Text] [Related]
12. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry. Lyles CM; Sandler RS; Keku TO; Kupper LL; Millikan RC; Murray SC; Bangdiwala SI; Ulshen MH Cancer Epidemiol Biomarkers Prev; 1994; 3(7):597-605. PubMed ID: 7827591 [TBL] [Abstract][Full Text] [Related]
13. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer. Oshima CT; Iriya K; Forones NM Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588 [TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and TLI in association with other prognostic parameters in breast cancer. Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571 [TBL] [Abstract][Full Text] [Related]
15. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
16. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
18. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma. Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225 [TBL] [Abstract][Full Text] [Related]
19. Proliferative activity in normal colon mucosa and tumor tissue: clinical implications. Balzi M; Becciolini A; Mauri P; Larosa V; Bechi P In Vivo; 1993; 7(6B):635-7. PubMed ID: 8193286 [TBL] [Abstract][Full Text] [Related]
20. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Scalmati A; Roncucci L; Ghidini G; Biasco G; Ponz de Leon M Cancer Res; 1990 Dec; 50(24):7937-41. PubMed ID: 2253235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]